PediaCare app helps guide parents

February 2011
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p40
Trade Publication
The article reports on the release of an iPhone application for the PediaCare children's over-the-counter (OTC) medicine line from Prestige Brands Inc. in the U.S.


Related Articles

  • Brands focus on lasting legacies.  // Drug Store News;6/25/2012, Vol. 34 Issue 8, p122 

    The article reports on the addition of 17 former Glaxosmithkline (GSK) brands to its stable of legacy brands that already includes Luden's and Dramamine by Prestige Brands Inc.

  • Prestige revenues dip, but income up 34%. Golden, John // Westchester County Business Journal;2/15/2010, Vol. 49 Issue 7, p2 

    The article reports on the 75.4 million dollars revenue loss of Prestige Brands Inc. despite the 34% increase of its income in the third fiscal quarter ending December 31, 2009 in Irvington, New York.

  • Chloraseptic, Luden's Lines Are Extended By Prestige.  // Chain Drug Review;10/22/2012, Vol. 34 Issue 18, p93 

    The article evaluates Warming Sore Throat Lozenges, a sore throat relief product, from Prestige Brands Inc.

  • Prestige Brands Offers $400M in HY. Sheahan, Matthew // High Yield Report;12/9/2013, p7 

    The article reports on the sale of senior notes due 2021 for 400 million dollars by medical products distributor Prestige Brands in December 2013.

  • Prestige Brands Prices $400M in Bonds. Sheahan, Matthew // High Yield Report;12/9/2013, p13 

    The article reports on the sale of senior notes amounting to 400 million dollars by medical products distributor Prestige Brands in December 2013.

  • A shot at new formats.  // Drug Store News;7/15/2013, Vol. 35 Issue 7, p40 

    The article reports on the move of the pharmaceutical company Prestige Brands Inc. to implement an energy shot format into its brands to infuse differentiation in the U.S.

  • MOST RECENT CLOSED U.S. LEVERAGED LOANS.  // Leveraged Finance News;2/13/2012, Vol. 2 Issue 7, p8 

    A table is presented which lists the most recent closed leveraged loans from various borrowers in the U.S. as of February 3, 2012 including Avis Budget Group Inc., Knoll Inc., and Prestige Brands Inc.

  • Acquisition a catalyst for Prestige.  // Chain Drug Review;2/13/2012, Vol. 34 Issue 3, p31 

    The article informs that the recent acquisition of several gastrointestinal brands of the pharmaceutical and consumer healthcare company, GlaxoSmithKline, including Tagamet, Beano and Gaviscon by Prestige Brands Inc. (PBI) has given PBI a higher profile in the digestives category.

  • Banks Prep $150M TLB, Notes for Prestige Brands. Kellerhals, Richard // High Yield Report;3/15/2010, Vol. 21 Issue 11, p19 

    The article reports on the 150-million-U.S.-dollar term loan B and the 150-million-U.S.-dollar senior notes arranged by Bank of America Merril Lynch and Deutsche Bank for Irvington, New York-based Prestige Brands.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics